When added to gene therapy, plant-based compound may enable faster, more effective treatments

Today's standard process for administering gene therapy is expensive and time-consuming — a result of the many steps required to deliver the healthy genes into the patients' blood stem cells to correct a genetic problem. Scientists believe they have found a way to sidestep some of the current difficulties, resulting in a more efficient gene delivery method that would save money and improve treatment outcomes.

Read more

Stem cell study offers new way to study early development and pregnancy

For the first time, researchers have created mouse blastocyst-like structures, or 'blastoids,' from a single cultured cell. The work could help advance research into development as well as inform issues around pregnancy, infertility, or health problems later in the offspring's life.

Read more

New marker for tumor aggression in neurofibromatosis type 1

A new study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggressive in those with NF1. According to the researchers, the clues could advance the search for more customized and relevant treatments that spare patients exposure to treatments unlikely to work.

Read more

Drug-light combo could offer control over CAR T-cell therapy

Bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells. The system requires two 'keys' — the drug Tamoxifen and blue light — to activate CAR T cells to bind to their targets.

Read more